1967
DOI: 10.5980/jpnjurol1928.58.2_210
|View full text |Cite
|
Sign up to set email alerts
|

The Urinary Excretion of Oxalic Acid in Urolithiasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1976
1976
2008
2008

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Due to the possibility of ethylene glycol toxicity upon presentation, thiamine and pyridoxine were administered as co-factors (27)(28)(29)(30). The role of these co-factors in diethylene glycol toxicity is unknown, but due to the relative safety of these agents in the doses given, we continued this therapy throughout the hospital course.…”
Section: Discussionmentioning
confidence: 97%
“…Due to the possibility of ethylene glycol toxicity upon presentation, thiamine and pyridoxine were administered as co-factors (27)(28)(29)(30). The role of these co-factors in diethylene glycol toxicity is unknown, but due to the relative safety of these agents in the doses given, we continued this therapy throughout the hospital course.…”
Section: Discussionmentioning
confidence: 97%
“…As a low, urinary excretion of magnesium may, from a physicochemical viewpoint, be expected to be associated with a reduced inhibitor activity and therefore an increased stone forming propensity, the urinary magnesium has been determined in a number of clinical studies. In general, stone formers appear to have a magnesium excretion not different from that of healthy nonstone forming subjects (1 1,20,26, 32, 40,47,48,52,53). In some studies, however, stone formers were reported to have a low urinary magnesium excretion, either in comparison with controls not matched for age and sex (19, 29, 34), or in comparison with an adequate matched control group (44,50).…”
Section: Magnesium Metabolism In Renal Stone Diseasementioning
confidence: 98%